Based on detection of delayed GFAP release in patients with ischemic stroke (maximum concentration reached 2–4 days after ischemic stroke onset), Foerch and his team studied this molecule in different clinical settings and showed promising results (79–81). Here, GFAP is linked to ischemic stroke.